Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The company also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its additional services include advanced biocontainment (BSL3), imaging services, animal model development, and IND-enabling services. Its lab services include cell-based assays, immunoassays, toxicity and cytotoxicity testing, viral load testing, and tailored assay development.
BIOQ stock price ended at $37.51 on 金曜日, after dropping 0.50%
On the latest trading day Feb 06, 2026, the stock price of BIOQ fell by 0.50%, dropping from $37.51 to $37.51. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $37.51 and a high of $37.51. On the latest trading day, the trading volume for BIOQ rose by 19 shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 233 shares were traded, with a market value of approximately $33.3M.